Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

Researchers have developed a tiny antibody that can find a common cancer protein and make tumors light up during PET scans. In tests with mice, tumors containing the protein EphA2 glowed clearly when ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

A small veterinary laboratory in California, VDI Labs, is helping more animals survive through early cancer detection – their new biomarker test will aid veterinarians and dog owners in the quest to ...

Fortunately, a PET scan showed no evidence of cancer in Romano’s body. Still, her doctor recommended continuing with what she described as a “protocol,” which includes supplements, eight weeks of ...